PerkinElmer Life Sciences Introduces KODAK MDS290 Microscopy Documentation System

Complete Solution for Light and Fluorescence Microscopy

22-Feb-2002 - BOSTON, MA - February 19, 2002 - PerkinElmer Life Sciences, a leading provider of drug discovery, life science research and genetic disease screening solutions, today announced the availability of the KODAK MDS290 for microscopy documentation that produces film-quality color images with the speed ...

Agilent Technologies releases new oligonucleotide microarray comparison study

21-Feb-2002 - PALO ALTO, Calif., February 20, 2002 -- Agilent Technologies Inc. today announced the release of a new study comparing 60-mer oligonucleotide microarray hybridization methods. This study compares Agilent’s standard procedure with two other hybridization protocols, evaluating all three based on ...

ImmunoGen and Millennium Sign Exclusive Product License

21-Feb-2002 - ImmunoGen, Inc. today announced that the Company and Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) have signed an exclusive product license for use of ImmunoGen's proprietary maytansinoid Tumor-Activated Prodrug (TAP) technology with Millennium's MLN591 antibody. This triggers Millennium's ...

SciQuest Launches Research Newsfeed and Private Portal Solutions Derived From Its SciCentral News Portal

Technology and content aggregation from award-winning portal will be licensed and syndicated

20-Feb-2002 - RESEARCH TRIANGLE PARK, N.C., Feb 19, 2002 (BW HealthWire) --SciQuest, Inc., a software, information and services company that provides solutions to enhance research operations for pharmaceutical, biotechnology and other research-based organizations, announced today two new products derived from ...

Extending the successful prevention of mental through newborn screening

19-Feb-2002 - When women with phenylketonuria (PKU) -a metabolic disorder diagnosed in newborns- do not follow a special diet, their babies are at risk for mental retardation. The results of a small interview study conducted by the Centers for Disease Control (CDC) are released today in the February 15, ...

Celera Compound Enters Development for Chagas' Disease

19-Feb-2002 - Rockville, MD and San Francisco, CA—February 14, 2002--Celera Genomics, an Applera Corporation business, announced today that the Institute for OneWorld Health (IOWH) and the National Institutes of Health (NIH) have initiated development of CRA-3316 as a potential new treatment for Chagas' ...

University of Pittsburgh Cancer Institute Launches Study on New Screening Tool for Early Detection of Lung Cancer

18-Feb-2002 - As one of the deadliest forms of cancer, lung cancer is often detected after symptoms have appeared and long after it has spread, resulting in a five-year survival rate of only 14 percent. While advances in surgery, chemotherapy and radiation may increase the length of survival in patients ...

3rd Millennium Receives SBIR Contract from Department of Defense to Develop Innovative Microarray Bioinformatics System

14-Feb-2002 - CAMBRIDGE, MA - February 13, 2002 -- 3rd Millennium, a leading bioinformatics consulting firm, announced today that is has received a Phase I Small Business and Innovation and Research (SBIR) contract from the Department of Defense (DOD) to develop an innovative bioinformatics system for the ...

PerkinElmer Life Sciences Introduces Protein S-Nitrosylation Detection Technology

New NitroGlo(TM) Detection Kit Offers New Capabilities for Neurobiology Researchers

14-Feb-2002 - BOSTON, MA - PerkinElmer Life Sciences, today announced the availability of NitroGlo(TM), a proprietary detection technology used to fingerprint precise S-nitrosylation (also known as S-nitrosation) sites on proteins. For the first time, researchers will be able to predict precise ...

Transgenomic and Max-Planck Institute collaborate

collaboration for the development of a high-throughput genetic variation discovery system

11-Feb-2002 - Transgenomic Inc. and the Berlin-Dahlem-based Max-Planck Institute for Molecular Genetics announced have entered into a multi-year collaboration for the development of a high-throughput genetic variation discovery system. Funded by the German National Genome Research Network (NGFN) and ...